From the ∗Department of Anatomical Pathology, Vancouver General Hospital

†Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

Reprints: Naveena Singh, MD, FRCPath, Department of Anatomical Pathology, Vancouver General Hospital, 855 W 12th Ave, Vancouver, British Columbia, Canada V5Z 1M9. E-mail: [email protected].

N.S. has received fees for participation in advisory boards hosted by AstraZeneca-MSD (Merck) and GlaxoSmithKline in 2019–2022. The other authors have no funding or conflicts to declare.